BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1703905)

  • 21. Production of leucocyte poor blood. A comparison of five different methods.
    Grunnet N; Rasmussen NJ
    Scand J Urol Nephrol Suppl; 1981; 64():106-11. PubMed ID: 6959257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].
    Budde U
    Beitr Infusionther Klin Ernahr; 1986; 15():75-81. PubMed ID: 3092802
    [No Abstract]   [Full Text] [Related]  

  • 23. [Production of leukocyte-poor erythrocyte concentrates with bedside filtration. Effectiveness and practicability of a new filter system in comparison with 2 other systems].
    Behr W
    Infusionstherapie; 1988 Dec; 15(6):245-50. PubMed ID: 3235203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood transfusion is never completely without side-effects. Filtrated erythrocyte concentrates should be used].
    Shanwell A
    Lakartidningen; 2000 Apr; 97(15):1782-3, 1786-7. PubMed ID: 10815405
    [No Abstract]   [Full Text] [Related]  

  • 25. Viability of 5-day apheresis platelets in a citrate-plasticized bag using a new cell separator.
    Simon TL; Moore RC; Sierra ER; Ferdinando B
    Prog Clin Biol Res; 1990; 337():11-3. PubMed ID: 2352969
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combination of a simple hollow fiber system with leukocyte filter for production of leukocyte depleted erythrocyte concentrates and plasma].
    Schwarzfischer G; Heim MU; Böck M; Kratzer MA; Mempel W
    Beitr Infusionsther; 1992; 30():287-91. PubMed ID: 1284718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphocyte contamination in thrombocyte concentrates from individual blood stores].
    Aulmann HM; Bremer A; Kathmann G; Müller R; Naumann V; Robin-Winn M; Stangel W
    Beitr Infusionsther; 1988; 21():109-12. PubMed ID: 2462954
    [No Abstract]   [Full Text] [Related]  

  • 28. [Initial results with the new cell separator AS 104].
    Kretschmer V; See A; Söhngen D; Bachem M; Kadar JG; Borberg H; Pelzer H; Zöfel P
    Beitr Infusionsther; 1988; 21():113-7. PubMed ID: 2462955
    [No Abstract]   [Full Text] [Related]  

  • 29. Automated blood component preparation with the Opti system: three years' experience.
    Högman CF; Eriksson L; Ring M
    Beitr Infusionsther; 1992; 30():100-7. PubMed ID: 1284683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombocyte collection with the cell separator. Determination of status and perspectives].
    Müller V; Borberg H
    Beitr Infusionther Klin Ernahr; 1986; 15():58-65. PubMed ID: 3753414
    [No Abstract]   [Full Text] [Related]  

  • 31. The IBM Blood Cell Separator and Blood Cell Processor: a personal perspective.
    Jones AL
    J Clin Apher; 1988; 4(4):171-82. PubMed ID: 3065330
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood component fractionation: manual versus automatic procedures.
    Pasqualetti D; Ghirardini A; Cristina Arista M; Vaglio S; Fakeri A; Waldman AA; Girelli G
    Transfus Apher Sci; 2004 Feb; 30(1):23-8. PubMed ID: 14746818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombocyte preparation from whole blood stores. Data on yield and leukocyte contamination].
    Mayer G; Wernet D; Schnaidt M; Sugg U
    Beitr Infusionther Klin Ernahr; 1986; 15():66-74. PubMed ID: 3753415
    [No Abstract]   [Full Text] [Related]  

  • 34. [Automated blood component collection with the MCS 3p].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1996; 33():145-9. PubMed ID: 8974687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.
    Weinreich SS; Remmerswaal EB; Laport R; van Rhenen DJ; Rombout-Sastrienkova E; Smit Sibinga CT; Vrielink H; Boog CJ
    Vox Sang; 2000; 79(2):83-6. PubMed ID: 11054045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation of leukocyte-poor erythrocyte concentrates by glycerin treatment and washing].
    Boye H; Vogler W; Strauss D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):437-43. PubMed ID: 2444519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discarded cellular components and the technical efficiency of component preparation.
    Veihola M; Aroviita P; Kekomäki R; Linna M; Sintonen H
    Eur J Health Econ; 2008 Nov; 9(4):325-31. PubMed ID: 17962987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Filtration of blood--useful or necessary?].
    Kretschmer V
    Infusionsther Transfusionsmed; 1995 Feb; 22(1):5-8. PubMed ID: 7727965
    [No Abstract]   [Full Text] [Related]  

  • 40. Separation of buffy coat using the top and bottom drainage system: reduction of red blood cell loss.
    Muylle L; Eerens D; Van Breedam B
    Transfus Sci; 1993 Oct; 14(4):399-403. PubMed ID: 10146647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.